谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

659 AN SINGLE-ARM OPEN-LABEL PHASE II STUDY OF CAMRELIZUMAB PLUS APATINIB AS SECOND-LINE TREATMENT FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Feng Wang,Qingxia Fan,Junsheng Wang,Tao Wu,Yonggui Hong,Xiangrui Meng,Zhonghai Ren,Yanzhen Guo,Xiuli Yang,Pei Shi,Jiamei Yang,Xianzhe Yin,Zhiquan Luo,Jin Xia,Yue Zhou,Enjie Liu,Guozhong Jiang

Diseases of the Esophagus（2021）

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要